Serostatus of IgG Antibody Against Mumps Virus in Adult Population of Al Madinah Al Munawarah, Saudi Arabia

Overview

Journal Saudi Med J

Specialty General Medicine

Date 2021 Aug 4

PMID 34344810

Citations 1

Authors

Waleed H Mahallawi

Mohiadeen M Kurdi

Nadir A Ibrahim

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the frequency and distribution of mumps-specific IgG antibodies among the healthy adult Saudi population in Al Madinah Al Munawarah, Saudi Arabia, where mandatory vaccination against measles-mumps-rubella (MMR) has been implemented for 30 years.

Methods: Qualitative and quantitative indirect enzyme-linked immunosorbent assay was performed to determine the mumps IgG antibody levels in sera collected from 429 individuals, including 224 men and 205 women. Participants were stratified into 3 age groups according to vaccination history (<20, 21-30, and >31 years).

Results: The overall seroprevalence of mumps antibodies in our population was 79.0%. The highest proportion of individuals with IgG antibody seropositivity, at 87.8% (95% confidence interval (95% CI): 84.7%-90.8%), was observed among the <20 years age group, who received 2 doses of vaccine. No significant relationships were observed between mumps seropositivity and age group or gender. The multivariable analysis identified the male gender and the age group >31 years as factors associated with an increased likelihood of seronegativity. Al Madinah Al Munawarah has achieved increased anti-mumps antibody seroprevalence since the implementation of the 2-dose MMR vaccination schedule.

Conclusions: Based on our study findings, we recommend that serological screening be performed to assess the need for mumps vaccination among adults at high risk for exposure and transmission.

Citing Articles

Exploring the Mumps Virus Glycoproteins: A Review.

Frost J, Shaikh S, Severini A Viruses. 2022; 14(6).

PMID: 35746805 PMC: 9229384. DOI: 10.3390/v14061335.

References

Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D . Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?. Epidemiol Infect. 2012; 141(3):651-66. PMC: 9152080. DOI: 10.1017/S0950268812001136. View

Santacruz-Sanmartin E, Hincapie-Palacio D, Ospina M, Perez-Toro O, Bernal-Restrepo L, Buitrago-Giraldo S . Seroprevalence of mumps in an epidemic period in Medellín, Colombia. Vaccine. 2015; 33(42):5606-5612. DOI: 10.1016/j.vaccine.2015.08.088. View

Rasheed M, Hickman C, McGrew M, Sowers S, Mercader S, Hopkins A . Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood. Proc Natl Acad Sci U S A. 2019; 116(38):19071-19076. PMC: 6754597. DOI: 10.1073/pnas.1905570116. View

Carr M, Moss E, Waters A, Dean J, Jin L, Coughlan S . Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J Clin Microbiol. 2010; 48(9):3288-94. PMC: 2937737. DOI: 10.1128/JCM.00434-10. View

Ma R, Lu L, Zhou T, Pan J, Chen M, Pang X . Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016. Vaccine. 2018; 36(19):2589-2595. DOI: 10.1016/j.vaccine.2018.03.074. View

Smits G, Mollema L, Hahne S, de Melker H, Tcherniaeva I, Waaijenborg S . Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. PLoS One. 2013; 8(3):e58234. PMC: 3592917. DOI: 10.1371/journal.pone.0058234. View

Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I . Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis. 2012; 206(10):1542-8. DOI: 10.1093/infdis/jis568. View

Philip J, Selvan D, Desmond A . Mumps orchitis in the non-immune postpubertal male: a resurgent threat to male fertility?. BJU Int. 2005; 97(1):138-41. DOI: 10.1111/j.1464-410X.2006.05902.x. View

Amanna I, Carlson N, Slifka M . Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007; 357(19):1903-15. DOI: 10.1056/NEJMoa066092. View

10.

Kenny L, OKelly E, Connell J, De Gascun C, Hassan J . Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus. J Clin Virol. 2015; 74:8-12. DOI: 10.1016/j.jcv.2015.11.023. View

11.

Damm O, Witte J, Wetzka S, Prosser C, Braun S, Welte R . Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. Int J Public Health. 2016; 61(7):847-60. PMC: 5002040. DOI: 10.1007/s00038-016-0842-8. View

12.

Lane T, Hines J . The management of mumps orchitis. BJU Int. 2005; 97(1):1-2. DOI: 10.1111/j.1464-410X.2006.05869.x. View

13.

Harling R, White J, Ramsay M, Macsween K, van den Bosch C . The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine. 2005; 23(31):4070-4. DOI: 10.1016/j.vaccine.2004.10.020. View

14.

Mahallawi W, Ibrahim N . Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia. Hum Vaccin Immunother. 2021; 17(8):2522-2529. PMC: 8475601. DOI: 10.1080/21645515.2021.1876486. View

15.

Coppeta L, Balbi O, Baldi S, Pietroiusti A, Magrini A . Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among Health Care Workers. Hum Vaccin Immunother. 2019; 15(5):1135-1138. PMC: 6605818. DOI: 10.1080/21645515.2018.1564442. View

16.

Fields V, Safi H, Waters C, Dillaha J, Capelle L, Riklon S . Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report. Lancet Infect Dis. 2019; 19(2):185-192. DOI: 10.1016/S1473-3099(18)30607-8. View

17.

Davidkin I, Kontio M, Paunio M, Peltola H . MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines. 2010; 9(9):1045-53. DOI: 10.1586/erv.10.99. View

18.

Tufenkeji H, Kattan H . Childhood immunization in the Kingdom of Saudi Arabia. Ann Saudi Med. 1994; 14(2):91-3. DOI: 10.5144/0256-4947.1994.91. View

19.

Schaffzin J, Pollock L, Schulte C, Henry K, Dayan G, Blog D . Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics. 2007; 120(4):e862-8. DOI: 10.1542/peds.2006-3451. View

20.

Pang H, Zhou Y, Zhao W, Jiang Q . Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China. Int J Environ Res Public Health. 2018; 15(10). PMC: 6210938. DOI: 10.3390/ijerph15102089. View